Download | October 5, 2018

The data in this report offers a thorough perspective for clinical development services segmented by phase, geography, and service line in an effort to determine the size of the CRO market. It includes information on estimated R&D expenditures through 2023, projected spending on development, Phase I-IV development, and outsourced Phase I-IV development through 2023 - segmented by sponsor type, spending on CRO services segmented by geography, service-line, and sponsor type, and more. You can purchase a single-user license for individual use, a site-wide license giving access to the report for all employees within a single site/office location, or an enterprise-wide license giving access to all employees within your organization. You can also download a free preview file below.

What you’ll learn:

  • Estimated R&D expenditures through 2023
  • Projected spending on development, Phase I-IV development, and outsourced Phase I-IV development through 2023, segmented by sponsor type:
    • Large pharma – large molecule
    • Large pharma – small molecule
    • Non-large pharma – large molecule
    • Non-large pharma – small molecule
    • Generic/Specialty
    • Government
    • Private
    • Association/Non-profit
    • Academic
  • Spending on CRO services segmented by:
    • Geography
    • Service-line
    • Phase I-IV

Learn more by downloading the free preview file, or by purchasing the full report below.